Chapter 30:: Parapsoriasis (and Pityriasis Lichenoides)
:: Stefan M. Schieke & Gary S. Wood
鄭煜彬(20200111)
| 
What entities are included in
  parapsoriasis?   | 
Large plaque parapsoriasis, small plaque
  parapsoriasis, & pityriasis lichenoids(PLEVA & PLC) | 
| 
What is Mucha-Habermann disease? | 
Pityriasis
  lichenoides et varioliformis acuta(PLEVA) | 
PARAPSORIASIS
| 
EPIDEMIOLOGY | |
| 
What is the range and peak of age in parapsoriasis?   | 
Middle-aged to older, fifth decade | 
| 
How much is the male-to-female ratio of SPP
  & LPP? | 
SPP: 3:1 
LPP: 1~: 1(M>F) | 
| 
CLINICAL FEATURES | |
| 
What is the clinical classification of
  SPP/LPP/PL?  | 
Papulosquamous lesions: papules with scales | 
| 
What is the symptoms of LPP? | 
Asymptomatic or mildly pruritic. | 
| 
What is the morphology of LPP? | 
Variable-sized(>5cm), light red-brown
  or salmon pink, oval or irregularly shaped, well-marginated patches or very thin plaques with small and scanty scales. | 
| 
What is the location of LPP? | 
“Bathing trunk(esp. breasts of women)”
  and flexural areas, as MF | 
| 
What material is used to describe to the
  fine wrinkle & epidermal atrophy of LPP?  | 
Cigarette paper | 
| 
What is the triad of poikiloderma?  | 
Telangiectasia, mottled pigmentation,
  & atrophy. 
(=poikiloderma atrophicans vasculare) | 
| 
What is the only variant of LPP? | 
Retiform parapsoriasis: scaly macules
  & papules in a net-like or zebra-stripe pattern | 
| 
What is chronic superficial dermatitis? | 
Small plaque parapsoriasis | 
| 
What is the morphology of SPP? | 
<5cm, round or oval discrete patches or very thin plaques with fine, moderately adherent scales.  | 
| 
What is the location of SPP? | 
Trunk | 
| 
What is two variants of SPP? | 
1.     
  digitate dermatosis 
2.     
  hypopigmented SPP  | 
| 
What is the morphology of digitate
  dermatosis? | 
A finger shape, yellowish or fawn-colored(淺黃褐色) lesions along the lines of cleavage. The long axis> 5cm.
  (xanthoerythrodermia perstans) | 
| 
What is the common complications of
  parapsoriasis(4)?  | 
1.     
  impetiginization secondary to
  excoriation 
2.     
  mycosis fungoides 
3.     
  Cardio/Cerebro-Vascular
  Diseases 
4.     
  Hematologic &
  nonhematologic malignancies | 
| 
ETIOLOGY & PATHOGENESIS | |
| 
Which two diseases are bridged by parapsoriasis?
   | 
Chronic dermatitis & mycosis
  fungoides (MF) | 
| 
What is the abnormal tissue of
  parapsoriasis or MF?  | 
Skin-associated lymphoid tissue (SALT): T
  cells express cutaneous lymphocyte-associated antigen | 
| 
Where does SALT locate?  | 
Skin, peripheral lymph nodes, lymphatics &
  blood-stream.(T-cells in the circuit, not a tissue) | 
| 
Why are MF, parapsoriasis & chronic
  dermatitis so difficult to distinguished?  | 
All continue to traffic and participate
  in delayed-type hypersensitivity reactions to contact allergens after
  neoplastic transformation. | 
| 
Please describe the relationship of LPP
  to MF.   | 
The clinically benign end of the MF
  disease spectrum: they are monoclonal disorders with different dominant
  T-cell clonal density | 
| 
What is the major factor to decide the
  clinical difference between parapsoriasis & MF?  | 
Genetic and/or epigenetic differences(the
  more mutations, the more malignant) | 
| 
How to name the chronic spongiotic dermatitis
  which may progress to MF?  | 
Clonal dermatitis | 
| 
Please draw a sketch of the relation
  between follicular mucinosis(FM); large-plaque parapsoriasis(LPP);
  nonspecific chronic spongiotic dermatitis(NCSD);  
primary erythroderma(PE); & clonal
  dermatitis? | |
| 
What is the difference between the clonal
  dermatitis & MF?  | 
Clonal
  dermatitis is polyclonal; MF is monoclonal. 
   | 
| 
Which virus may induce MF?  | 
HHV-8 | 
| 
DIAGNOSIS | |
| 
What is the clinical difference between
  LPP & SPP?  | 
LPP has larger size, asymmetric distribution, irregular shape, less
  discrete lesions, & poikilodermatous appearance.  | 
| 
What is the difference between LPP &
  patch stage of MF? | 
No
  diffenrence(indistinguishable) | 
| 
What is the main difference between
  parapsoriasis & MF? | 
Parapsoriasis has no induration or palpable infiltration | 
| 
What is the criteria to diagnose MF? | |
| 
Since LPP& MF are indistinguishable,
  why should we use the name LPP?  | 
1.     
  It guides treatment and
  followup as MF  
2.     
  The risk of dying from
  lymphoma(MF) is small. | 
| 
What is the major difference between SPP
  & MF?  | 
MF had poikiloderma, moderate to thick
  plaques.  | 
| 
PATHOLOGY | |
| 
What can you see in the slide of early
  SPP?(Please answer according to epidermis & dermis)  | 
E: mild spongiosis + focal hyperkeratosis,
  parakeratosis(scale), crust, & exocytosis. 
D: mild superficial perivascular
  lymphohistiocytic infiltrate + edema | 
| 
What can you see in the slide of late
  SPP? | 
As early SPP (no progression) | 
| 
What can you see in the slide of early LPP? | 
E: mildly acanthotic & hyperkeratotic
  epidermis + spotty parakeratosis. 
D: Perivascular & scattered dermal
  lymphocytic infiltrate | 
| 
What can you see in the slide of advanced
  LPP or MF? | 
An interface infiltrate + mild spongiosis
  + epidermotropism (scattered singly or in groups). 
Poikiloderma: atrophic epidermis, dilated
  blood vessels, & melanophage | 
| 
What are the different immunohistologic
  features between SPP & LPP/early MF?  | 
(CD4+ T-cells predominate in these
  dermatitides) LPP/MF has CD7 deficiency, epidermal expression of HLD-DR.    | 
| 
DIFFERENTIAL DIAGNOSIS | |
| 
What is the difference between SPP/LPP/MF
  & psoriasis?  | 
Psoriasis has Auspitz sign, micaceous
  scale, nail  
pits, & lesions on the scalp, elbows,
  & knees. | 
| 
CLINICAL COURSE AND PROGNOSIS | |
| 
How many percent of cases of LPP &
  SPP become MF in the future?  | 
LPP: 10% to 30% 
SPP: 0% | 
| 
Which variant of LPP usually progress to
  MF?  | 
The retiform variant | 
| 
MANAGEMENT | |
| 
How to treat SPP?  | 
Emollients, topical tarcortic/osteroids,
  & BBUVB 
F/u every 3-6 months.  | 
| 
How to treat LPP? | 
Topical: strong corticosteroids, nitrogen
  mustard 
Phototherapy: BB/NBUVB, UVA1, PUVA, excimer 
F/u every 3-6 months. | 
| 
How to treat MF?  | 
Phototherapy: BBUVB, NBUVB, UVA1, PUVA 
Topical: nitrogen mustard, bexarotene
  gel, imiquimod, carmustine (BCNU).  
Electron-beam radiation | 
 


 
No comments:
Post a Comment